CC
RPRX icon

Cipher Capital’s Royalty Pharma RPRX Stock Holding History

Cipher Capital’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$350K Sell
11,515
-4,953
-30% -$146K 0.16% 228
2023
Q4 		$463K Buy
16,468
+2,335
+17% +$64.2K 0.15% 224
2023
Q3 		$384K Buy
+14,133
New +$420K 0.27% 131

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cipher Capital's RPRX Position: Q1 2024 in Review

Cipher Capital reduced its Royalty Pharma (RPRX) stake by 30% in Q1 2024, selling an estimated $146K and leaving 11,515 shares worth $350K. The position accounts for 0.16% of the portfolio, ranked #228.

Cipher Capital first reported a position in RPRX in Q3 2023 and has held it in 3 quarters since. The position peaked at $463K in Q4 2023. 378 funds tracked by Wall St. Rank hold RPRX as of Q1 2024.

  • Cipher Capital held 11,515 shares of Royalty Pharma worth $350K as of Q1 2024.
  • Cipher Capital sold 4,953 Royalty Pharma shares in Q1 2024, an estimated $146K.
  • Royalty Pharma made up 0.16% of Cipher Capital's portfolio in Q1 2024, its #228 holding.
  • Cipher Capital first reported a position in Royalty Pharma in Q3 2023 and has held it in 3 quarters since.
  • Cipher Capital's Royalty Pharma position peaked at $463K in Q4 2023.
  • 378 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2024.

Based on Cipher Capital's 13F filing for Q1 2024, filed 15 May 2024.